Digital Preservation
This journal follows the standards defined in the SciELO Program's Digital Preservation Policy
Open Data
BJCVS is committed to the Guidelines for promoting openness, transparency and reproducibility of research published by SciELO journals (TOP Guidelines), aiming to improve the quality and transparency of published research. These guidelines emphasize the importance of clarity in the evidence supporting study conclusions.
To align with these principles, BJCVS requests that all datasets associated with submitted manuscripts be accompanied by the Open Science Compliance Form. This form must be completed in detail by the authors, highlighting how the research adheres to Open Science standards, and submitted as a Supplemental File with the manuscript.
This practice ensures that all relevant data is available for review and analysis, contributing to the integrity and reproducibility of scientific research. Adherence to these guidelines reinforces BJCVS's commitment to transparency and excellence in scientific publishing.
Clinical Trial Data: For manuscripts reporting clinical trial data, BJCVS adopts the recommendations of the International Committee of Medical Journal Editors (ICMJE) on the sharing of such data. Data availability statements should be clear and detailed, including the following information:
- Data Availability with Controlled Access:
- The statement should explain the reasons for controlled access, such as privacy issues or ethical and legal considerations.
- Access conditions must be accurately described, including contact information for access requests and deadlines for response.
- Any restrictions on data usage, such as data use agreements, must be clearly indicated. A copy or link to the data use agreement must be available if requested by the editors.
- Restrictions on data reuse or authorship requirements must be explicitly described in the manuscript and communicated to the editors at the time of submission.
- Editors retain the right to refuse manuscript consideration if data access restrictions are excessively restrictive.
- Third Party Data:
- Where data obtained from third parties cannot be shared, specific restrictions should be clearly stated in the data availability statement.
- Authors must make data available for peer review, if requested, respecting the terms of any data use agreement and in compliance with ethical and legal requirements.
- Citation Standards: All data, program codes, and methods must be appropriately cited using DOIs, journal citations or other persistent identifiers. Exceptional situations that require different treatment, such as confidential information under non-disclosure agreements, must be communicated to the editor up to the manuscript review stage and clearly mentioned in the Acknowledgements (see Citations and References).
- Data Standards: All data used must be accessible to any researcher for the purpose of reproducing or expanding the analysis. Data should either be included in the article or deposited in specialized community repositories or general-purpose repositories. Some examples include Dryad, Figshare, Zenodo, Mendeley Data, OSF, and the SciELO Data repository. Special situations, such as privacy protection or the acquisition of data from third parties, should be discussed with the editor as early as possible and clearly indicated in the Acknowledgments.
- Transparency in Analytical Methods (Code): The Methods section should provide sufficient detail to allow study replication. Materials or samples used in the analysis must be available to any researcher for direct replication. Any restrictions on material availability, as well as Material Transfer Agreements (MTAs), must be disclosed to the editor until the manuscript review stage and specified in the Acknowledgments.